CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Hematopoietic Stem Cell Transplantation :A curative treatment for potentially fatal disorders

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 112
Year: 2016
COI code: IPMCMED01_007
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Hematopoietic Stem Cell Transplantation :A curative treatment for potentially fatal disorders

  Mahshid Mehdizadeh - Shahid Beheshti university of medical sciences

Abstract:

A variety of hematological disorders of the bone marrow, such as acute leukemia, chronicmyelocytic leukemia and severe aplastic anemia, were invariably known as fatal disorders. In the past two decades, physicians have been able to change this reality into a more hopeful outcome byreplacing the diseased bone marrow with stem cells from either a family or an unrelated donor with identical human leukocyte antigens (HLA).Based on the rapid progression in the field of stem cell transplantation donor banks now are considered a necessity.Considering stem cell transplantation we can treat some malignant disorders with Intending to cure.Timing of hematopoietic stem cell transplantation is the most important point to achieve cure in malignant disorders. Distinct indications are shown for HSCT in Acute myeloblastic and lymphoblastic leukemia, aplastic anemia, multiple myeloma and relapsed Hodgkin and non Hodgkin lymphomas which benefit the most. Preparing the patients for on time HSCT is key point of success. Achievement of complete remission before HSCT and finding the best donor in family members or unrelated ones are corner stones of transplantation .There are someethical concerns for donors and families, concerns that need to be discussed and understood by patients, donors and health care professionals.

Keywords:

stem cell,hematopoietic,transplantation,malignancy

Perma Link

https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_007.html
COI code: IPMCMED01_007

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Mehdizadeh, Mahshid, 2016, Hematopoietic Stem Cell Transplantation :A curative treatment for potentially fatal disorders, First Personal Medical Congress, تهران, دانشگاه علوم پزشكي ايران - پژوهشكده ملي مهندسي ژنتيك و زيست فناوري ايران، مركز همكاري هاي فناوري و نوآوري هاي رياست جمهوري, https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_007.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Mehdizadeh, Mahshid, 2016)
Second and more: (Mehdizadeh, 2016)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.